111 Capital Invests $167,000 in UiPath, Inc. $PATH

111 Capital purchased a new position in UiPath, Inc. (NYSE:PATH) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 13,025 shares of the company’s stock, valued at approximately $167,000.

A number of other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of UiPath by 3.0% in the first quarter. Vanguard Group Inc. now owns 48,061,096 shares of the company’s stock worth $495,029,000 after acquiring an additional 1,396,972 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in UiPath by 10.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,132,003 shares of the company’s stock worth $63,164,000 after buying an additional 602,866 shares during the last quarter. Federated Hermes Inc. boosted its stake in UiPath by 479.3% during the first quarter. Federated Hermes Inc. now owns 5,720,096 shares of the company’s stock worth $58,917,000 after buying an additional 4,732,712 shares during the last quarter. Acadian Asset Management LLC boosted its stake in UiPath by 222.6% during the first quarter. Acadian Asset Management LLC now owns 4,241,047 shares of the company’s stock worth $43,667,000 after buying an additional 2,926,263 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in UiPath by 6.3% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,995,632 shares of the company’s stock worth $30,855,000 after buying an additional 177,071 shares during the last quarter. 62.50% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Brad Brubaker sold 66,665 shares of the firm’s stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $15.00, for a total transaction of $999,975.00. Following the transaction, the insider owned 690,519 shares in the company, valued at $10,357,785. This trade represents a 8.80% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Daniel Dines sold 122,733 shares of the firm’s stock in a transaction that occurred on Wednesday, September 17th. The stock was sold at an average price of $11.71, for a total value of $1,437,203.43. Following the transaction, the chief executive officer owned 2,454,667 shares in the company, valued at $28,744,150.57. This represents a 4.76% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,569,600 shares of company stock worth $19,791,809 in the last 90 days. 23.19% of the stock is currently owned by company insiders.

UiPath Stock Performance

PATH opened at $14.82 on Wednesday. UiPath, Inc. has a one year low of $9.38 and a one year high of $15.93. The company has a market cap of $7.87 billion, a P/E ratio of 494.10, a PEG ratio of 5.37 and a beta of 1.07. The business’s 50-day simple moving average is $11.67 and its 200-day simple moving average is $11.91.

UiPath (NYSE:PATH) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.07. The business had revenue of $361.73 million for the quarter, compared to the consensus estimate of $347.36 million. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The business’s revenue for the quarter was up 14.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.04 EPS. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, analysts predict that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on PATH shares. DA Davidson started coverage on UiPath in a research note on Friday, September 5th. They set a “neutral” rating and a $12.00 price objective on the stock. Zacks Research raised UiPath from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 8th. Wall Street Zen raised UiPath from a “buy” rating to a “strong-buy” rating in a research note on Saturday, September 6th. Cowen reissued a “hold” rating on shares of UiPath in a research note on Friday, September 5th. Finally, Canaccord Genuity Group lowered their price objective on UiPath from $16.00 to $15.00 and set a “buy” rating on the stock in a research note on Monday, September 8th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, twelve have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $13.21.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.